Trial Profile

Phase I FIH, Randomized, Placebo-controlled, Double-blind Trial Evaluating Safety and Tolerability of Ex Vivo Deceased-donor Kidney Allograft Treatment With TUM012 to Minimize Ischemic Reperfusion Injury After Kidney Transplantation

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 11 Jun 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

03 Jun 2024 Status changed from active, no longer recruiting to completed.
29 Nov 2023 Phase of the trial changed from phase 1 to phase 1/2.
15 Nov 2023 According to an iCoat Medical media release, the company were able to start the work linked to publications and presentations at international scientific conferences.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com